World Intellectual Property Organization

Examples of EPO applications set aside, modified or withdrawn based on TKDL evidence

(Information courtesy of the Council of Scientific and Industrial Research)

Earlier intention to grant a patent set aside by EPO:

  • EP1520585: EPO decided to grant patent to M/s. Data Medica, Padova SPA, Italy on 19.2.2009 for use of Pista as an anti-cancer drug. Evidence submitted by TKDL Unit, CSIR, India on 09.07.2009, based upon which the EPO set aside its earlier intention to grant patent on 14.07.2009.
  • EP1747786: EPO decided to grant patent to M/s. Perdix Eurogroup SL, Spain on 02.04.2009 for use of watery extract of Kharbooza /melon as an anti-vitilgo cream. Evidence submitted by TKDL Unit, CSIR, India on 08.07.2009, based upon which the EPO set aside its earlier intention to grant patent on 28.7.2009.

Claims of the application modified the applicant:

  • EP1849473: EPO decided to grant patent to M/s. Livzon Pharmaceutical Group Inc., China on 25.02.2010 for use of Kalamegha and Mint for the treatment of avian influenza. Evidence submitted by TKDL Unit, CSIR, India on 20.05.2010, based upon which the EPO set aside its earlier intention to grant patent on 10.6.2010. Subsequently M/s. Livzon Pharmaceutical Group Inc modified its claims on 05.07.2010 in the independent use of Kalamegha and Mint for the treatment of avian influenza.

Claims/applications withdrawn by the applicant:

  • EP1781309: M/s Purimed Co. LTD., Korea filed a patent application on 09-06-2005 for treatment of heart diseases using Indian lotus. Evidence submitted by TKDL Unit, CSIR, India on 17-07-2009. On 04-08-2009 applicant decided to withdraw its claims / patent application.
  • EP1807098: M/s Amcod Limited, Kenya filed a patent application on13-09-2005 for treatment of diabetes using Neem, Gheekawaar and Daal Chini. Evidence submitted by TKDL Unit, CSIR, India on 01-07-2009. On 24-11-2009 applicant decided to withdraw its claims / patent application.
  • EP2116253: M/s Phytrix JV, LLC, USA, filed a patent application on 07.05.2008 using Phyllanthus / Bhumi aamla for the treatment of HIV associated diseases. Evidence submitted by TKDL Unit, CSIR, India on 03.08.2010. On 28-09-2010 applicant decided to withdraw its claims / patent application.
  • EP1971354: M/s Seoul National University Industry Foundation, Korea, filed a patent application on 05.01.2007 using licorice / Mulaithi for the treatment of liver diseases. Evidence submitted by TKDL Unit, CSIR, India on 04.05.2010. On 21-10-2010 applicant decided to withdraw its claims / patent application.

 

Explore WIPO